- $2.06bn
- $2.20bn
- $465.75m
- 70
- 58
- 72
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 298 | 328 | 330 | 347 | 373 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 292 | 316 | 342 | 343 | 370 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 125 | 155 | 188 | 180 | 154 |
Provision for Income Taxes | |||||
Net Income After Taxes | 103 | 128 | 154 | 148 | 127 |
Net Income Before Extraordinary Items | |||||
Net Income | 103 | 128 | 154 | 148 | 127 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 103 | 128 | 154 | 148 | 127 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.29 | 8.33 | 9.6 | 9.06 | 7.8 |
Dividends per Share | |||||
Special Dividends per Share |